Treatment & Management
The research led by this Think Tank aims to optimize treatment strategies for people living and aging with HIV and STBBIs to promote long-term engagement in care, reduce comorbidities, and improve quality of life.
-
CTN 307: ECF/TAF Switch in opioid substitution therapy
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy — A Pilot Feasibility Study
-
CTN 294: The LAGHDA Study
Longitudinal Analysis of HIV Genetic Diversification under Antiretroviral therapy (LAHGDA)
-
-
CTNPT 037: Smartphone assessment of medicinal and non-medicinal cannabis use
Disentangling medicinal and non-medicinal cannabis use among people living with HIV: Feasibility of a smartphone-based assessment
-
CTN 315: The KIND Study
Kids Imaging and Neurocognitive Development (KIND) Thanks to advances in treatment, many women living with HIV can get pregnant with minimal risk of giving birth to a child who has the virus. While most children who are HIV-exposed but uninfected (CHEU) are in good health, it is unclear how exposure to HIV and antiretroviral therapy…
-
CTN 272-2: The Canadian HIV & Aging Cohort Study 2.0
Discovering pathways to successful aging in people living with HIV